Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.

European journal of human genetics : EJHG - 1 Apr 2018

Littlejohn Lucy A, Gibbs Jim, Jordan Lee B, Miedzybrodzka Zosia H, Bell Christine, Goudie David, Dunlop Jacqueline, Berg Jonathan N

Abstract excerpt

Breast cancer risk is a common indication for referral to clinical genetics services. UK National Institute of Health and Care Excellence (NICE) guidelines use family history (FH) to stratify by 10-year risk of breast cancer from age 40. Patients are stratified into population risk (PR, 10-year risk <3%), moderate (MR, 3-8%) and high risk (HR, >8%). Women at increased risk are offered screening at or prior to age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Penetrance

Share to Practice Guidelines as Topic

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 29335492
DOI: 10.1038/s41431-017-0072-4
PMCID: PMC5891489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.PMID 29335492Read ↗

Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.Semantic proximity Read ↗

Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancerSemantic proximity Read ↗

Clinicopathological Characteristics and Treatment Outcomes in Breast Cancer in Women Under 50: A Real-World UK Cohort StudySemantic proximity Read ↗

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women.Semantic proximity Read ↗

Establishing a family risk assessment clinic for breast cancer.Semantic proximity Read ↗

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity Read ↗

How much does genetics add to screening? Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.Semantic proximity Read ↗

A primary care audit of familial risk in patients with a personal history of breast cancer.Semantic proximity Read ↗

Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.Semantic proximity Read ↗

Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.Semantic proximity Read ↗

Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines.Semantic proximity Read ↗

Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.